Your browser doesn't support javascript.
loading
Etanercept therapy leads to reductions in matrix metalloproteinase-3 in patients with erosive hand osteoarthritis.
Kroon, Fpb; Bay-Jensen, A C; Wittoek, R; Verbruggen, G; Smolen, J S; Kloppenburg, M; Ramonda, R.
Affiliation
  • Kroon F; Department of Rheumatology, Leiden University Medical Center, Leiden, The Netherlands.
  • Bay-Jensen AC; Biomarker and Research, Nordic Bioscience, Herlev, Denmark.
  • Wittoek R; Department of Rheumatology, Ghent University Hospital, Ghent, Belgium.
  • Verbruggen G; Department of Rheumatology, Ghent University Hospital, Ghent, Belgium.
  • Smolen JS; Division of Rheumatology, Department of Internal Medicine III, Medical University of Vienna, Vienna, Austria.
  • Kloppenburg M; Department of Rheumatology, Leiden University Medical Center, Leiden, The Netherlands.
  • Ramonda R; Department of Clinical Epidemiology, Leiden University Medical Center, Leiden, The Netherlands.
Scand J Rheumatol ; 49(2): 167-168, 2020 Mar.
Article in En | MEDLINE | ID: mdl-31566063
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Osteoarthritis / Matrix Metalloproteinase 3 / Etanercept Type of study: Clinical_trials Limits: Aged / Female / Humans / Male / Middle aged Language: En Journal: Scand J Rheumatol Year: 2020 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Osteoarthritis / Matrix Metalloproteinase 3 / Etanercept Type of study: Clinical_trials Limits: Aged / Female / Humans / Male / Middle aged Language: En Journal: Scand J Rheumatol Year: 2020 Document type: Article Affiliation country: Country of publication: